No homozygous deletion of SMN2 has been identified in SMA patients, supporting the hypothesis that the complete loss of SMN1 and SMN2 would result in embryonic or fetal lethality [6]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.